![Susan G. Komen: Tarah Ballinger presents results from the EAZ171 trial at ASCO24](https://oncodaily.com/pub/uploads/2024/06/Susan-G.-Komen.jpeg)
Photo from Susan G. Komen/X
Jun 5, 2024, 12:51
Susan G. Komen: Tarah Ballinger presents results from the EAZ171 trial at ASCO24
Tarah Ballinger, Assistant Professor of Clinical Medicine at Indiana University School of Medicine, shared a post by Susan G. Komen, on X/Twitter, adding:
”Thank you Susan G. Komen for your support!!”
Quoting Susan G. Komen’s post:
”Komen grantee Tarah Ballinger presents results from the EAZ171 trial at ASCO24. The results showed that docetaxel resulted in less grade 2 neuropathy, a painful side effect from some chemotherapy drugs, than paclitaxel for Black women.”
Source: Tarah Ballinger/X and Susan G. Komen/X